| Code | Description | Claims | Beneficiaries | Total Paid |
| X4011 |
State-specific procedure code |
686 |
562 |
$113K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,004 |
767 |
$79K |
| Y7506 |
|
636 |
513 |
$76K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,013 |
818 |
$75K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
533 |
434 |
$29K |
| 80053 |
Comprehensive metabolic panel |
473 |
387 |
$24K |
| 86140 |
|
128 |
109 |
$12K |
| Y7507 |
|
35 |
30 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
156 |
108 |
$9K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
84 |
72 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
151 |
130 |
$6K |
| 87428 |
|
180 |
176 |
$5K |
| 81001 |
|
60 |
51 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14 |
12 |
$3K |
| 83735 |
|
13 |
13 |
$2K |
| J3490 |
Unclassified drugs |
72 |
52 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
132 |
120 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
78 |
76 |
$510.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14 |
12 |
$445.02 |
| 81003 |
|
111 |
89 |
$194.08 |
| 83605 |
|
27 |
25 |
$153.88 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$98.92 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
29 |
13 |
$72.18 |
| A9270 |
Non-covered item or service |
33 |
15 |
$0.00 |